Summary
NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString's nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Washington, the US.
NanoString Technologies Inc (NSTG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NanoString Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NanoString Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NanoString Technologies Inc, Medical Equipment, Deal Details 12
Venture Financing 12
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 12
NanoString Technologies To Raise US$0.65 Million In Venture Financing 13
NanoString Technologies Secures US$20 Million In Series D Financing 14
NanoString Technologies Secures US$2.5 Million In Venture Financing 15
Partnerships 16
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Technologies Enters into Co-Development Agreement with HalioDx 17
NanoString Technologies Enters into Agreement with Cell Signaling Technology 17
Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma 18
Merck Sharp & Dohme Expands its Agreement with NanoString Technologies 19
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 20
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 21
NanoString Enters into Research Agreement with Brigham and Women’s Hospital 22
NanoString Enters into Co-Development Agreement with Celgene 22
NanoString Technologies Enters Into Option Agreement With Broad Institute To License Liver Cancer Gene Signature 23
Equity Offering 24
NanoString Technologies Raises USD57.8 Million in Public Offering of Shares 24
NanoString to Raise USD40 Million in Public Offering of Shares 26
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 27
NanoString Technologies Completes IPO Of Shares For US$54 Million 28
NanoString Technologies Inc - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
May 04, 2017: NanoString Technologies Releases Operating Results for First Quarter of 2017 33
Mar 01, 2017: NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook 34
Jan 10, 2017: NanoString Technologies Provides Preliminary Operational and Financial Results for 2016 35
Nov 02, 2016: NanoString Technologies Releases Operating Results for Third Quarter of 2016 36
Aug 03, 2016: NanoString Technologies Releases Operating Results for Second Quarter of 2016 37
May 05, 2016: NanoString Technologies Releases Operating Results for First Quarter of 2016 38
Feb 29, 2016: NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook 39
Jan 10, 2016: NanoString Technologies Provides Preliminary Operational and Financial Results for 2015 41
Corporate Communications 42
May 10, 2017: NanoString Appoints Elisha W. Finney to Board of Directors 42
Sep 13, 2016: NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors 43
Product News 44
Apr 03, 2017: Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors 44
Mar 29, 2017: NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research 46
Mar 27, 2017: NanoString Highlights a Record Number of nCounter-Based Research Abstracts in Precision Oncology and Predictive Biomarkers at the 2017 American Association of Cancer Research Annual Meeting 47
Mar 23, 2017: NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies 50
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrate a Novel Approach for High-Plex 52
Feb 27, 2017: The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrates at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium 53
Nov 30, 2016: NanoString Technologies Highlights Advances in Precision Oncology at the 58th Annual Meeting of the American Society of Hematology 54
Nov 18, 2016: NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples 56
Nov 07, 2016: NanoString Launches Technology Access Program (TAP) for Transformative Platform for High-Plex Digital Spatial Profiling 57
Jun 02, 2016: NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) 58
Apr 14, 2016: NanoString Technologies Unveils New nCounter Vantage Assays to Power Cancer Research With 3D Biology 61
Feb 09, 2016: American Society of Clinical Oncology Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63
List of Tables
NanoString Technologies Inc, Medical Equipment, Key Facts, 2016 1
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NanoString Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NanoString Technologies Inc, Deals By Market, 2011 to YTD 2017 9
NanoString Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NanoString Technologies Raises US$0.2 Million In Venture Financing 12
NanoString Technologies Raises US$15 Million In Series E Financing 12
NanoString Technologies To Raise US$0.65 Million In Venture Financing 13
NanoString Technologies Secures US$20 Million In Series D Financing 14
NanoString Technologies Secures US$2.5 Million In Venture Financing 15
NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 16
NanoString Technologies Enters into Co-Development Agreement with HalioDx 17
NanoString Technologies Enters into Agreement with Cell Signaling Technology 17
Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma 18
Merck Sharp & Dohme Expands its Agreement with NanoString Technologies 19
NanoString Enters into Research Agreement with CITN for Novel Cancer Immunotherapies 20
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 21
NanoString Enters into Research Agreement with Brigham and Women’s Hospital 22
NanoString Enters into Co-Development Agreement with Celgene 22
NanoString Technologies Enters Into Option Agreement With Broad Institute To License Liver Cancer Gene Signature 23
NanoString Technologies Raises USD57.8 Million in Public Offering of Shares 24
NanoString to Raise USD40 Million in Public Offering of Shares 26
NanoString Technologies Completes Public Offering Of Shares For US$55 Million 27
NanoString Technologies Completes IPO Of Shares For US$54 Million 28
NanoString Technologies Inc, Key Competitors 30
NanoString Technologies Inc, Key Employees 31
List of Figures
NanoString Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
NanoString Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NanoString Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
NanoString Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NanoString Technologies Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
